SCHEMBL21166020

SCHEMBL21166020

CC(C)(C)NC1CCCCC1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19367684 0.82 SIGMAR1 (0.30) —
SCHEMBL6659778 0.82 SIGMAR1 (0.30) —
SCHEMBL22210750 0.79 SIGMAR1 (0.33) —
Hydrochloric Acid SCHEMBL6663231 0.77 — —
SCHEMBL6665913 0.76 — —
SCHEMBL24316208 0.73 SIGMAR1 (0.30) —
SCHEMBL10267303 0.73 EPHX1 (0.39) —
SCHEMBL20063377 0.73 SIGMAR1 (0.30) —
SCHEMBL20880512 0.72 — —
SCHEMBL6888123 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10774064-B2 Potassium channel modulators CADENT THERAPEUTICS, INC. (US) 2020-09-15 — — US disclosed
US-20190218200-A1 POTASSIUM CHANNEL MODULATORS NOVARTIS AG (CH) 2019-07-18 — — US disclosed
Send feedback